Magnetic resonance imaging interactions with a sacral neuromodulation system.
Xuechen Huang1, Guangqiang Jay Jiang1
1Axonics Inc., Irvine, CA, USA.
Neurourology and Urodynamics
|September 6, 2021
Summary
New sacral neuromodulation systems are now MRI conditional, allowing full-body scans. Physicians must follow manufacturer guidelines for safe Magnetic Resonance Imaging (MRI) procedures with these devices.
Area of Science:
- Medical Devices
- Neuroscience
- Radiology
Background:
- Sacral neuromodulation (SNM) effectively treats functional urinary and bowel disorders.
- Historically, SNM systems posed contraindications for Magnetic Resonance Imaging (MRI) scans.
- Recent FDA approvals allow specific SNM systems for MRI conditional full-body scans.
Purpose of the Study:
- To review the evolution of MRI compatibility for SNM systems.
- To highlight the importance of understanding MRI safety for active implantable medical devices (AIMDs).
- To inform physicians about advancements in MRI-eligible SNM technology.
Main Methods:
- Explanation of MRI physics and its interaction with AIMDs.
- Identification of potential safety hazards, focusing on radio frequency (RF) related risks.
- Discussion of risks associated with "off-label" scans and lead complications.
Main Results:
- Newer SNM systems (Axonics, Medtronic InterStim II/Micro) have received FDA approval for 1.5T and 3T full-body MRI conditional scans.
- Understanding MRI safety for these devices is crucial due to technological advancements.
- Manufacturer guidelines are essential for safe scanning.
Conclusions:
- Adherence to device manufacturer's MRI guidelines is paramount for patient safety.
- Thorough understanding of specific device conditions is necessary.
- Avoid generalizations about MRI safety based on limited data.


